This Frost & Sullivan report analyzes the markets for a full range of HIV and AIDS pharmaceutical products, including protease inhibitors, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, anti-cytomegalovirus drugs and anitfungal drugs. The report examines industry challenges and provides recommendations for spurring growth. It also provides thorough analyses of the competitive field for each product segment in eight European regional markets. Key companies in the industry are profiled.
